Gulf Coast Health Partners
ACO FAQs Partners Locations Find a Physician Education & Events Contact Us
         
Home>>   
an Accountable Care Organization
Consent Forms, Quality Measurements, Patient Portal, Healthy Communities        

Quality Measurements - 2015

Download the quality measurements table in a printable format >>

Measure Number Measure Name 2015 Reporting Period
ACO Performance Rate Mean performance rate (SSP-ACOs)
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 78.92 80.61
ACO-2 CAHPS: How Well Your Providers Communicate 91.68 92.65
ACO-3 CAHPS: Patients’ Rating of Provider 92.70 91.94
ACO-4 CAHPS: Access to Specialists 82.07 83.61
ACO-5 CAHPS: Health Promotion and Education 54.79 59.06
ACO-6 CAHPS: Shared Decision Making 71.24 75.17
ACO-7 CAHPS: Health Status/Functional Status 69.43 72.30
ACO-34 CAHPS: Stewardship of Patient Resources* 26.62 26.87
ACO-8 Risk Standardized, All Condition Readmission 14.60 14.86
ACO-35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)* Readmission 19.70 18.07
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes* 43.83 54.60
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure* 68.16 76.96
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 57.68 62.92
ACO-9 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 1.16 1.11
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) 0.88 1.04
ACO-11 Percent of Primary Care Physicians who Successfully Meet Meaningful Use Requirements 91.51 80.14
ACO-39 Documentation of Current Medications in the Medical Record* 97.32 84.07
ACO-13 Falls: Screening for Future Fall Risk 65.22 56.46
ACO-14 Preventive Care and Screening: Influenza Immunization 72.97 62.03
ACO-15 Pneumonia Vaccination Status for Older Adults 62.80 63.73
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up 70.43 71.15
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 81.04 90.16
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 65.57 45.25
ACO-19 Colorectal Cancer Screening 69.90 60.06
ACO-20 Breast Cancer Screening 68.85 65.67
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 84.75 70.04
ACO-40 Depression Remission at Twelve Months* N/A N/A
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 19.57 20.38
ACO-41 Diabetes: Eye Exam* 51.90 41.05
ACO-28 Hypertension: Controlling High Blood Pressure 72.74 69.62
ACO-30 Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic 82.06 83.82
ACO-31 Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LSVD) 92.72 87.22
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Blocker Receptor
Therapy - for patients with CAD and Diabetes or Left Ventricular Dysfunction Systolic (LVEF<40%)
84.03 77.73
CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease
*= Measure required beginning Reporting Year 2015.
N/A= Reporting on the depression remission measure is not required for 2015, as indicated by N/A

2012-2014 Quality Measurements

Public Reporting Information


 
 
Partners: Sacred Heart Health System and Providence Health System
Sacred Heart Health System Providence Health System Consent Forms Quality Measurements Patient Portal Healthy Communities Public Reporting Information Gulf Coast Health Partners